Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - MediChem Life Sciences (NasdaqNM:MCLS)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Recent Events
Aug 21Price hit new 52-week low ($1.24)
Aug  8Earnings Announcement
Location
2501 Davey Road
Woodridge, IL 60517
Phone: (630) 783-4600
Fax: (630) 783-4705
Email: webmaster@medichem.com
Employees (last reported count): 217
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 63%
·Institutional: 27% (74% of float)
(31 institutions)
·Net Inst. Selling: 902.0K shares (+14.16%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Medichem Life Sciences, Inc. is a drug discovery technology and services company that offers a broad range of integrated chemistry research and development capabilities to pharmaceutical and biotechnology companies. The Company offers chemistry services that span the entire drug development spectrum, from early stage discovery technologies and services up until a potential drug enters clinical testing. Medichem has developed proprietary platform technologies in the areas of proteomics, biocatalysis, chiral chemistry and automated process research. These technologies utilize automation and optimization to compress the drug discovery process timeline and are adaptable to multiple customer applications.
More from Market Guide: Expanded Business Description

Financial Summary
MediChem Life Sciences, Inc. is a drug discovery technology and services company that offers a range of integrated chemistry R&D capabilities to pharmaceutical and biotechnology companies. For the six months ended 6/30/01, revenues rose 21% to $10.8 million. Net loss applicable to Common increased 89% to $5.7 million. Results reflect higher contract revenues due to acquisitions and sales growth, offset by increased depreciation and research and development expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Michael Flavin, Ph.D., 45
Chairman, Pres, CEO
$184K
Lance Stewart, Ph.D., 36
Pres--Emerald BioStructures
--  
R. Richard Wieland II, 56
Exec. VP, CFO
150K
John Flavin, 32
Exec. VP, COO, Director
154K
Jeffrey Whitnell, 45
VP-Fin., Treasurer
139K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:MCLSAs of 31-Aug-2001
Price and Volume
52-Week Low
on 21-Aug-2001
$1.24 
Recent Price$1.55 
52-Week High
on 28-June-2001
$5.28 
Daily Volume (3-month avg)164.6K
Daily Volume (10-day avg)31.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y]
13-Week Change-41.3%
13-Week Change
relative to S&P500
-34.7%
Share-Related Items
Market Capitalization$41.2M
Shares Outstanding26.6M
Float9.80M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$2.60 
Earnings (ttm)-$1.16 
Earnings (mrq)-$0.14 
Sales (ttm)$1.02 
Cash (mrq)$0.41 
Valuation Ratios
Price/Book (mrq)0.60 
Price/EarningsN/A 
Price/Sales (ttm)1.52 
Income Statements
Sales (ttm)$21.2M
EBITDA (ttm)-$6.14M
Income available to common (ttm)-$22.0M
Profitability
Profit Margin (ttm)-41.7%
Operating Margin (ttm)-61.7%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-9.81%
Return on Equity (ttm)-40.17%
Financial Strength
Current Ratio (mrq)3.33 
Debt/Equity (mrq)0.21 
Total Cash (mrq)$10.8M
Short Interest
As of 8-Aug-2001
Shares Short1,000 
Percent of Float0.0%
Shares Short
(Prior Month)
4,000 
Short Ratio0.00 
Daily Volume240.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.